Europe — EMA
Obracin (Tobramycin)
Tobramycin, the active ingredient in Obracin, is an aminoglycoside antibiotic presented as a strength/form for topical use. It treats bacterial eye infections and is used in patients requiring ophthalmic therapy.
Request sourcing
What is Tobramycin?
Tobramycin, the active ingredient in Obracin, is an aminoglycoside antibiotic presented as a strength/form for topical use. It treats bacterial eye infections and is used in patients requiring ophthalmic therapy.
GNH USA supplies Obracin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Tobramycin used for?
Obracin is an aminoglycoside antibiotic that targets bacterial infections of the eye. - Bacterial conjunctivitis: reduces the bacterial load and alleviates redness and discharge. - Bacterial keratitis: helps to eradicate the causative organisms and promotes corneal healing. - Post‑operative ocular surgery prophylaxis: prevents infection after eye procedures. - Contact lens‑associated infection by Pseudomonas aeruginuses or other Gram‑negative organisms. - Eye ulcers that may progress to corneal scarring if untreated.
What are the side effects of Tobramycin?
Adverse reactions to Tobramycin ophthalmic preparations are generally mild and localized.
Common Side Effects: - Burning sensation: transient discomfort on instillation. - Redness: mild conjunctival hyperemia. - Tearing: increased lacrimation. - Foreign‑body sensation: feeling of grit. - Blurred vision: temporary visual disturbance.
Serious or Rare Side Effects: - Corneal ulceration: persistent epithelial defect. - Hypersensitivity reaction: rash, itching, or swelling of the eyelid. - Vision loss: rapid deterioration of visual acuity. - Anaphylaxis: systemic allergic response requiring emergency care. - Endophthalmitis: intra‑ocular infection. - Keratitis: inflammation of the cornea beyond expected irritation.
What precautions apply to Tobramycin?
When using Obracun (likely a topical ophthalmic preparation), consider the following safety measures: - Renal function: assess the risk of systemic absorption especially if used on large ocular surfaces. - Auditory monitoring: monitor for signs of ototoxic c c c c c c. - Concomitant ototoxic drugs: avoid co‑administration with other aminoglycosides. - Contact lens wear: advise patients to remove the lenses before application. - Pregnancy ": - Store at ": -
What does Tobramycin interact with?
The
Product details
Related products

TOBREX 3 mg/g
Tobramycin · 3 mg/g

Tobramycin 300 mg/4mL
Tobramycin · 300 mg/4 mL

Tobramycin 300 mg/4mL
Tobramycin · 300 mg/4 mL

Tobramycin 300 mg/5mL
Tobramycin · 300 mg/5 mL